ARTHUR MADER

428 total citations
51 papers, 229 citations indexed

About

ARTHUR MADER is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, ARTHUR MADER has authored 51 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 16 papers in Surgery and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in ARTHUR MADER's work include Lipoproteins and Cardiovascular Health (13 papers), Cardiovascular Function and Risk Factors (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). ARTHUR MADER is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Cardiovascular Function and Risk Factors (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). ARTHUR MADER collaborates with scholars based in Liechtenstein, Austria and United States. ARTHUR MADER's co-authors include Heinz Drexel, Christoph H. Saely, Alexander Vonbank, Andreas Leiherer, Christine Heinzle, Axel Muendlein, Alessandro Trentini, Charlotte E. Teunissen, Gerhard Bachmaier and Christian Enzinger and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

ARTHUR MADER

41 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
ARTHUR MADER Liechtenstein 9 58 52 51 46 37 51 229
Taku Inokuchi Japan 9 51 0.9× 63 1.2× 38 0.7× 14 0.3× 70 1.9× 16 300
Filip Sköldberg Sweden 10 147 2.5× 49 0.9× 21 0.4× 26 0.6× 40 1.1× 20 355
Lia Gutiérrez United States 10 59 1.0× 76 1.5× 55 1.1× 20 0.4× 42 1.1× 22 351
Jin Cao China 9 54 0.9× 39 0.8× 23 0.5× 35 0.8× 79 2.1× 28 264
Anna Popławska‐Kita Poland 11 46 0.8× 198 3.8× 38 0.7× 21 0.5× 87 2.4× 49 396
Mi Yeon Kang South Korea 10 39 0.7× 42 0.8× 21 0.4× 16 0.3× 119 3.2× 29 291
Xixiang Tang China 13 54 0.9× 149 2.9× 16 0.3× 84 1.8× 69 1.9× 31 386
Miguel Ángel Gómez-Sámano Mexico 9 52 0.9× 102 2.0× 22 0.4× 24 0.5× 122 3.3× 23 311
Jindra Windrichová Czechia 11 21 0.4× 37 0.7× 21 0.4× 34 0.7× 59 1.6× 26 288
So Ueda Japan 6 49 0.8× 83 1.6× 31 0.6× 55 1.2× 45 1.2× 6 317

Countries citing papers authored by ARTHUR MADER

Since Specialization
Citations

This map shows the geographic impact of ARTHUR MADER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ARTHUR MADER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ARTHUR MADER more than expected).

Fields of papers citing papers by ARTHUR MADER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ARTHUR MADER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ARTHUR MADER. The network helps show where ARTHUR MADER may publish in the future.

Co-authorship network of co-authors of ARTHUR MADER

This figure shows the co-authorship network connecting the top 25 collaborators of ARTHUR MADER. A scholar is included among the top collaborators of ARTHUR MADER based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ARTHUR MADER. ARTHUR MADER is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MADER, ARTHUR, Jörn F. Dopheide, Christoph H. Saely, et al.. (2025). Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis. Scientific Reports. 15(1). 2792–2792. 1 indexed citations
2.
Mündlein, Axel, Alexander Vonbank, ARTHUR MADER, et al.. (2024). 25 years of lipid-lowering therapy: secular trends in therapy of coronary patients. Wiener klinische Wochenschrift. 137(9-10). 297–306. 2 indexed citations
3.
Drexel, Heinz, ARTHUR MADER, Andreas Festa, et al.. (2024). Remnant cholesterol and long-term incidence of death in coronary artery disease patients. Atherosclerosis. 401. 119048–119048. 2 indexed citations
4.
5.
Drexel, Heinz & ARTHUR MADER. (2023). Bempedoic Acid: How Will It Shape the Future Lipid-Lowering Landscape? Mode of Action, Evidence, and Clinical Use. Cardiology. 149(1). 71–77. 3 indexed citations
6.
MADER, ARTHUR, Alexander Vonbank, THOMAS PLATTNER, et al.. (2023). 260-OR: The ApoB/LDL-C Ratio Predicts Major Cardiovascular Events in Cardiovascular Disease Patients Independent of Type 2 Diabetes Status. Diabetes. 72(Supplement_1). 1 indexed citations
7.
Muendlein, Axel, Christine Heinzle, Andreas Leiherer, et al.. (2023). Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure. Clinical Biochemistry. 121-122. 110675–110675. 3 indexed citations
8.
Muendlein, Axel, Eva Maria Brandtner, Andreas Leiherer, et al.. (2022). Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography. Data in Brief. 42. 108142–108142. 2 indexed citations
9.
MADER, ARTHUR, Alexander Vonbank, Andreas Leiherer, et al.. (2021). Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease. BMJ Open Diabetes Research & Care. 9(2). e002407–e002407. 10 indexed citations
10.
Saely, Christoph H., ARTHUR MADER, Beatrix Mutschlechner, et al.. (2021). REMNANT CHOLESTEROL IN PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE PREDICTS CARDIOVASCULAR EVENTS BOTH AMONG PATIENTS WITH TYPE 2 DIABETES AND AMONG NON-DIABETIC SUBJECTS. Journal of the American College of Cardiology. 77(18). 1565–1565. 1 indexed citations
11.
Saely, Christoph H., Alexander Vonbank, ARTHUR MADER, et al.. (2021). CHRONIC KIDNEY DISEASE IS A TYPE 2 DIABETES RISK EQUIVALENT IN PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 77(18). 1513–1513. 1 indexed citations
12.
Drexel, Heinz, et al.. (2021). Downhill hiking improves low-grade inflammation, triglycerides, body weight and glucose tolerance. Scientific Reports. 11(1). 14503–14503. 6 indexed citations
13.
Drexel, Heinz, ARTHUR MADER, Alexander Vonbank, et al.. (2021). The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease. Atherosclerosis. 329. 44–49. 23 indexed citations
14.
Saely, Christoph H., Alexander Vonbank, ARTHUR MADER, et al.. (2021). Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuria. Journal of Diabetes and its Complications. 35(12). 108046–108046.
15.
Leiherer, Andreas, Axel Muendlein, Christoph H. Saely, et al.. (2021). COMPARISON OF TWO RECENT CERAMIDE-BASED CORONARY RISK PREDICTION SCORES: CERT AND CERT-2. Journal of the American College of Cardiology. 77(18). 1568–1568.
16.
Muendlein, Axel, Kathrin Geiger, Andreas Leiherer, et al.. (2021). THE NEW MYOKINE MYONECTIN IS SIGNIFICANTLY ASSOCIATED WITH TYPE 2 DIABETES IN PATIENTS WITH PERIPHERAL ARTERY DISEASE. Journal of the American College of Cardiology. 77(18). 1791–1791. 1 indexed citations
17.
Saely, Christoph H., Alexander Vonbank, Christine Heinzle, et al.. (2020). Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease. Journal of Diabetes and its Complications. 34(11). 107692–107692. 11 indexed citations
18.
Vonbank, Alexander, et al.. (2020). Usefulness of Handgrip Strength to Predict Mortality in Patients With Coronary Artery Disease. The American Journal of Cardiology. 129. 5–9. 14 indexed citations
19.
Leiherer, Andreas, Axel Muendlein, Kathrin Geiger, et al.. (2019). TARGETED METABOLOMICS IDENTIFIES ELEVATED SEROTONIN LEVELS IN CARRIERS OF A TCF7L2 DIABETES-RISK ALLELE. Journal of the American College of Cardiology. 73(9). 2119–2119. 1 indexed citations
20.
Saely, Christoph H., Alexander Vonbank, Christine Heinzle, et al.. (2019). Pro-B-Type Natriuretic Peptide Strongly Predicts Future Cardiovascular Events In Cardiovascular Disease Patients With Type 2 Diabetes As Well As In Those Without Type 2 Diabetes. Atherosclerosis. 287. e189–e189. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taku Inokuchi Breakdown of academic impact, for papers by Filip Sköldberg Breakdown of academic impact, for papers by Lia Gutiérrez Breakdown of academic impact, for papers by Jin Cao Breakdown of academic impact, for papers by Anna Popławska‐Kita Breakdown of academic impact, for papers by Mi Yeon Kang Breakdown of academic impact, for papers by Xixiang Tang Breakdown of academic impact, for papers by Miguel Ángel Gómez-Sámano Breakdown of academic impact, for papers by Jindra Windrichová Breakdown of academic impact, for papers by So Ueda
Rankless by CCL
2026